BRCA1 and neoplasm: Interestingly, TNBC is associated with an increased deoxyribonucleic acid (DNA)-repair defect in the tumor cells, which is caused either by germline mutations in genes such as BRCA1/2, PALB2, and others [23, 24] or by a somatic HRD, which can be exploited by systemic therapies [21].